Inmed announces closing of us$4.5 million private placement

Vancouver, bc, feb. 16, 2021 /prnewswire/ - inmed pharmaceuticals inc. ("inmed" or the "company") (nasdaq: inm) (tsx: in), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol...
INM Ratings Summary
INM Quant Ranking